0000899243-22-020487.txt : 20220601
0000899243-22-020487.hdr.sgml : 20220601
20220601173441
ACCESSION NUMBER: 0000899243-22-020487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220527
FILED AS OF DATE: 20220601
DATE AS OF CHANGE: 20220601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iskra Michael S.
CENTRAL INDEX KEY: 0001839432
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41409
FILM NUMBER: 22988480
MAIL ADDRESS:
STREET 1: C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS
STREET 2: 1001 ROUTE 202
CITY: RARITAN
STATE: NJ
ZIP: 08869
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QuidelOrtho Corp
CENTRAL INDEX KEY: 0001906324
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 552-1100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Coronado Topco, Inc.
DATE OF NAME CHANGE: 20220124
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-27
0
0001906324
QuidelOrtho Corp
QDEL
0001839432
Iskra Michael S.
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
Stock Options
59.53
2022-05-27
4
A
0
22020
0.00
A
2025-12-21
Common Stock
22020
22020
D
Stock Options
119.06
2022-05-27
4
A
0
16809
0.00
A
2024-05-27
Common Stock
16809
16809
D
Restricted Stock Units
2022-05-27
4
A
0
15825
0.00
A
Common Stock
15825
15825
D
Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
Vested in full.
9,804 shares are vested in full; 7,005 shares will vest on July 1, 2022.
Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.
Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
15,825 shares will vest on April 1, 2023.
/s/ Phillip S. Askim, attorney-in-fact for Michael S. Iskra
2022-06-01